T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells

Autor: Carola Ries, Amélie M. Bilocq, Barbara Molon, Andrielly H. R. Agnellini, Franz Kratochvill, Bernhard Mlecnik, Jérôme Galon, Valeria Runza, Emilia Maria Cristina Mazza, Vincenzo Bronte, Giacomo Desantis, Ilaria Marigo, Sabine Hoves, Maria Stella Sasso, Joseph E. Qualls, Silvio Bicciato, Gabriela Bindea, Stefano Ugel, Peter J. Murray, Serena Zilio, Paola Zanovello
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Cancer Research
CD30
Cytotoxic
medicine.medical_treatment
T-Lymphocytes
cance
Adoptive
Nitric Oxide Synthase Type II
cance
therapy
tumor
dendritic cells
necrosis

Inbred C57BL
Immunotherapy
Adoptive

necrosis
Mice
0302 clinical medicine
Cancer immunotherapy
Neoplasms
Tumor Microenvironment
Cytotoxic T cell
Melanoma
Mice
Knockout

Tumor
biology
Chemistry
Nitric oxide synthase
medicine.anatomical_structure
Oncology
030220 oncology & carcinogenesis
Cd40 cd40l
Tumor necrosis factor alpha
Immunotherapy
Animals
Arginase
CD40 Antigens
CD40 Ligand
Cell Line
Tumor

Dendritic Cells
Humans
Mice
Inbred C57BL

T-Lymphocytes
Cytotoxic

Tumor Necrosis Factor-alpha
T cell
Knockout
Cancer therapy
Article
Cell Line
03 medical and health sciences
medicine
Tumor microenvironment
therapy
CD40
Cell Biology
030104 developmental biology
Immunology
Cancer cell
biology.protein
Cancer research
Popis: Summary Effective cancer immunotherapy requires overcoming immunosuppressive tumor microenvironments. We found that local nitric oxide (NO) production by tumor-infiltrating myeloid cells is important for adoptively transferred CD8 + cytotoxic T cells to destroy tumors. These myeloid cells are phenotypically similar to inducible nitric oxide synthase (NOS2)- and tumor necrosis factor (TNF)-producing dendritic cells (DC), or Tip-DCs. Depletion of immunosuppressive, colony stimulating factor 1 receptor (CSF-1R)-dependent arginase 1 + myeloid cells enhanced NO-dependent tumor killing. Tumor elimination via NOS2 required the CD40-CD40L pathway. We also uncovered a strong correlation between survival of colorectal cancer patients and NOS2, CD40, and TNF expression in their tumors. Our results identify a network of pro-tumor factors that can be targeted to boost cancer immunotherapies.
Databáze: OpenAIRE